204 related articles for article (PubMed ID: 20407014)
1. Targeted knockdown of SEPT9_v1 inhibits tumor growth and angiogenesis of human prostate cancer cells concomitant with disruption of hypoxia-inducible factor-1 pathway.
Amir S; Golan M; Mabjeesh NJ
Mol Cancer Res; 2010 May; 8(5):643-52. PubMed ID: 20407014
[TBL] [Abstract][Full Text] [Related]
2. SEPT9_v1 up-regulates hypoxia-inducible factor 1 by preventing its RACK1-mediated degradation.
Amir S; Wang R; Simons JW; Mabjeesh NJ
J Biol Chem; 2009 Apr; 284(17):11142-51. PubMed ID: 19251694
[TBL] [Abstract][Full Text] [Related]
3. SEPT9_i1 is required for the association between HIF-1α and importin-α to promote efficient nuclear translocation.
Golan M; Mabjeesh NJ
Cell Cycle; 2013 Jul; 12(14):2297-308. PubMed ID: 24067372
[TBL] [Abstract][Full Text] [Related]
4. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
Vardi-Oknin D; Golan M; Mabjeesh NJ
PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
[TBL] [Abstract][Full Text] [Related]
5. Imaging of hypoxia-inducible factor 1α and septin 9 interaction by bimolecular fluorescence complementation in live cancer cells.
Golan M; Mabjeesh NJ
Oncotarget; 2017 May; 8(19):31830-31841. PubMed ID: 28380438
[TBL] [Abstract][Full Text] [Related]
6. Septin 9 isoform 1 (SEPT9_i1) specifically interacts with importin-α7 to drive hypoxia-inducible factor (HIF)-1α nuclear translocation.
Tazat K; Schindler S; Depping R; Mabjeesh NJ
Cytoskeleton (Hoboken); 2019 Jan; 76(1):123-130. PubMed ID: 29742803
[TBL] [Abstract][Full Text] [Related]
7. [Mechanism of nuclear translocation of hypoxia-inducible factor-1α in influenza A (H1N1) virus infected-alveolar epithelial cells].
Meng X; Guo X; Zhu Y; Xie H; Wang R
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2020 Jan; 32(1):8-13. PubMed ID: 32148224
[TBL] [Abstract][Full Text] [Related]
8. MSF-A interacts with hypoxia-inducible factor-1alpha and augments hypoxia-inducible factor transcriptional activation to affect tumorigenicity and angiogenesis.
Amir S; Wang R; Matzkin H; Simons JW; Mabjeesh NJ
Cancer Res; 2006 Jan; 66(2):856-66. PubMed ID: 16424018
[TBL] [Abstract][Full Text] [Related]
9. SEPT9_V1 protein expression is associated with human cancer cell resistance to microtubule-disrupting agents.
Amir S; Mabjeesh NJ
Cancer Biol Ther; 2007 Dec; 6(12):1926-31. PubMed ID: 18075300
[TBL] [Abstract][Full Text] [Related]
10. SEPT9_i1 regulates human breast cancer cell motility through cytoskeletal and RhoA/FAK signaling pathway regulation.
Zeng Y; Cao Y; Liu L; Zhao J; Zhang T; Xiao L; Jia M; Tian Q; Yu H; Chen S; Cai Y
Cell Death Dis; 2019 Sep; 10(10):720. PubMed ID: 31558699
[TBL] [Abstract][Full Text] [Related]
11. Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.
Yu S; Xu Z; Zou C; Wu D; Wang Y; Yao X; Ng CF; Chan FL
J Pathol; 2014 Dec; 234(4):514-25. PubMed ID: 25065497
[TBL] [Abstract][Full Text] [Related]
12. Rhapontigenin inhibited hypoxia inducible factor 1 alpha accumulation and angiogenesis in hypoxic PC-3 prostate cancer cells.
Jung DB; Lee HJ; Jeong SJ; Lee HJ; Lee EO; Kim YC; Ahn KS; Chen CY; Kim SH
Biol Pharm Bull; 2011; 34(6):850-5. PubMed ID: 21628883
[TBL] [Abstract][Full Text] [Related]
13. Cyclin-dependent kinase inhibitor, P276-00, inhibits HIF-1α and induces G2/M arrest under hypoxia in prostate cancer cells.
Manohar SM; Padgaonkar AA; Jalota-Badhwar A; Rao SV; Joshi KS
Prostate Cancer Prostatic Dis; 2012 Mar; 15(1):15-27. PubMed ID: 22083267
[TBL] [Abstract][Full Text] [Related]
14. Epidithiodiketopiperazines (ETPs) exhibit in vitro antiangiogenic and in vivo antitumor activity by disrupting the HIF-1α/p300 complex in a preclinical model of prostate cancer.
Reece KM; Richardson ED; Cook KM; Campbell TJ; Pisle ST; Holly AJ; Venzon DJ; Liewehr DJ; Chau CH; Price DK; Figg WD
Mol Cancer; 2014 Apr; 13():91. PubMed ID: 24775564
[TBL] [Abstract][Full Text] [Related]
15. Suppression of TRPM7 Inhibited Hypoxia-Induced Migration and Invasion of Androgen-Independent Prostate Cancer Cells by Enhancing RACK1-Mediated Degradation of HIF-1
Yang F; Cai J; Zhan H; Situ J; Li W; Mao Y; Luo Y
Oxid Med Cell Longev; 2020; 2020():6724810. PubMed ID: 32215176
[TBL] [Abstract][Full Text] [Related]
16. ERRα augments HIF-1 signalling by directly interacting with HIF-1α in normoxic and hypoxic prostate cancer cells.
Zou C; Yu S; Xu Z; Wu D; Ng CF; Yao X; Yew DT; Vanacker JM; Chan FL
J Pathol; 2014 May; 233(1):61-73. PubMed ID: 24425001
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic delivery of siRNA silencing HIF-1 alpha with micellar nanoparticles inhibits hypoxic tumor growth.
Liu XQ; Xiong MH; Shu XT; Tang RZ; Wang J
Mol Pharm; 2012 Oct; 9(10):2863-74. PubMed ID: 22924580
[TBL] [Abstract][Full Text] [Related]
18. Effects of geldanamycin on HIF-1alpha mediated angiogenesis and invasion in prostate cancer cells.
Alqawi O; Moghaddas M; Singh G
Prostate Cancer Prostatic Dis; 2006; 9(2):126-35. PubMed ID: 16432534
[TBL] [Abstract][Full Text] [Related]
19. A novel resveratrol analogue, HS-1793, inhibits hypoxia-induced HIF-1α and VEGF expression, and migration in human prostate cancer cells.
Kim DH; Hossain MA; Kim MY; Kim JA; Yoon JH; Suh HS; Kim GY; Choi YH; Chung HY; Kim ND
Int J Oncol; 2013 Dec; 43(6):1915-24. PubMed ID: 24100602
[TBL] [Abstract][Full Text] [Related]
20. Silibinin inhibits hypoxia-induced HIF-1α-mediated signaling, angiogenesis and lipogenesis in prostate cancer cells: In vitro evidence and in vivo functional imaging and metabolomics.
Deep G; Kumar R; Nambiar DK; Jain AK; Ramteke AM; Serkova NJ; Agarwal C; Agarwal R
Mol Carcinog; 2017 Mar; 56(3):833-848. PubMed ID: 27533043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]